-
2025Implementation evaluation of a school- and primary care-based multicomponent intervention to improve HPV vaccine coverage: Results from the PrevHPV randomized controlled trial., J Infect Public Health 2025 Aug; 18(11): 102931.
-
2025The effect of school-based interventions on HPV vaccine-related knowledge, attitudes, and practices among adolescents in France: Secondary results from the PrevHPV trial., Vaccine 2025 Aug; 61(): 127344.
-
2025Co-designing a shared digital decision aid for HPV vaccination in French general practice., BMC Prim Care 2025 Jul; 26(1): 215.
-
2025Improving human papillomavirus vaccination coverage in France: a need to act but not to rush., Nat Commun 2025 Jun; 16(1): 5346.
-
2025Communicating on Vaccine Benefit-Risk Ratios: A Discrete-Choice Experiment among Health Care Professionals and the General Population in France., Med Decis Making 2025 Feb; 45(2): 177-191.
-
2025Are psychological attitudes towards vaccination an expression of personality? A cross-sectional study on COVID-19 vaccination in France., BMC Public Health 2025 Jan; 25(1): 209.
-
2025What are parents’ preferences for Human Papillomavirus vaccination promotion messages and communication? Application of a discrete choice experiment to a French Caribbean setting., BMC Public Health 2025 Jan; 25(1): 145.
-
2025Filling the Gap to Address Vaccine Hesitancy in Europe., Public Health Rev 2025 ; 46(): 1608208.
-
2025Effect of a multicomponent HPV intervention on self-reported HPV vaccine uptake and intention among French adolescents and parents: results from the national, cluster-randomised PrevHPV trial., BMJ Public Health 2025 ; 3(2): e001007.
-
2024Sociodemographic determinants of HPV vaccine awareness, uptake, and intention among parents of adolescents in France 2021-22., Hum Vaccin Immunother 2024 Dec; 20(1): 2381300.
-
2024Shared human papillomavirus vaccine readiness within families: A psychometric analysis of parent-adolescent dyads in France., Health Psychol 2024 Dec; 43(12): 893-903.
-
2024New pedagogical tools for vaccine education: preparing future healthcare workers for the next pandemic., BMC Med Educ 2024 Nov; 24(1): 1314.
-
2024Analyzing the 7C psychological antecedents of vaccine acceptance throughout the COVID-19 pandemic among healthcare sector workers in France: A repeated cross-sectional study (CappVac-Cov)., Vaccine 2024 Oct; 42(24): 126103.
-
2024Optimizing Communication on HPV Vaccination to Parents of 11- to 14-Year-Old Adolescents in France: A Discrete Choice Experiment., Patient 2024 Sep; 17(5): 575-588.
-
2024Providing parents with HPV vaccine information from a male perspective may render them more inclined to have their daughters vaccinated., Infect Dis Now 2024 Jun; 54(4): 104908.
-
2024Effectiveness of a School- and Primary Care-Based HPV Vaccination Intervention: The PrevHPV Cluster Randomized Trial., JAMA Netw Open 2024 May; 7(5): e2411938.
-
2024Are the 7C psychological antecedents associated with COVID-19 vaccine behaviours beyond intentions? A cross-sectional study on at-least-one-dose and up-to-date vaccination status, and uptake speed among adults in France, Vaccine, 2024, S0264-410X (24), pp.00438-9. ⟨10.1016/j.vaccine.2024.04.024⟩.
-
2024Do boys have the same intentions to get the HPV vaccine as girls? Knowledge, attitudes, and intentions in France., Vaccine 2024 Apr; 42(10): 2628-2636.
-
2024The intentions of French health university students to recommend and to receive the HPV vaccine are mainly influenced by vaccine knowledge, confidence in vaccines and personal HPV vaccination., Vaccine 2024 Mar; 42(8): 1934-1940.
-
2024Barriers and facilitators to the HPV vaccine: a multicenter qualitative study of French general practitioners., Arch Public Health 2024 Jan; 82(1): 2.
-
2023Psychometric validation of a 7C-model of antecedents of vaccine acceptance among healthcare workers, parents and adolescents in France., Sci Rep 2023 Nov; 13(1): 19895.
-
2023Can physicians and schools mitigate social inequalities in human papillomavirus vaccine awareness, uptake and vaccination intention among adolescents? A cross-sectional study, France, 2021 to 2022., Euro Surveill 2023 Nov; 28(46): .
-
2023Co-development of a school-based and primary care-based multicomponent intervention to improve HPV vaccine coverage amongst French adolescents (the PrevHPV Study)., Health Expect 2023 Oct; 26(5): 1843-1853.
-
2023Impact of a COVID-19 certificate requirement on vaccine uptake pattern and intention for future vaccination. A cross-sectional study among French adults., Vaccine 2023 Aug; 41(37): 5412-5423.
-
2023Informing a target product profile for rapid tests to identify HBV-infected pregnant women with high viral loads: a discrete choice experiment with African healthcare workers., BMC Med 2023 Jul; 21(1): 243.
-
2023What motivates adults to accept influenza vaccine? An assessment of incentives, ease of access, messaging, and sources of information using a discrete choice experiment., SSM Popul Health 2023 Jun; 22(): 101384.
-
2023Promoting HPV vaccination at school: a mixed methods study exploring knowledge, beliefs and attitudes of French school staff., BMC Public Health 2023 Mar; 23(1): 486.
-
2023Preferences for COVID-19 epidemic control measures among French adults: a discrete choice experiment., Eur J Health Econ 2023 Feb; 24(1): 81-98.
-
2023Serogroup B meningococcal vaccines from the public health perspective., Lancet Infect Dis 2023 Jan; 23(1): 13-14.
-
2022High-spatial resolution epidemic surveillance of bacterial meningitis in the African meningitis belt in Burkina Faso., Sci Rep 2022 Nov; 12(1): 19451.
-
2022Attitudes of healthcare professionals toward the COVID-19 vaccination campaign in France., Infect Dis Now 2022 Nov; 52(8S): S21-S22.
-
2022Social conformism and confidence in systems as additional psychological antecedents of vaccination: a survey to explain intention for COVID-19 vaccination among healthcare and welfare sector workers, France, December 2020 to February 2021., Euro Surveill 2022 Apr; 27(17): .
-
2022Impact of a school-based and primary care-based multicomponent intervention on HPV vaccination coverage among French adolescents: a cluster randomised controlled trial protocol (the PrevHPV study)., BMJ Open 2022 Mar; 12(3): e057943.
-
2022Vaccine eagerness: A new framework to analyse preferences in single profile discrete choice experiments. Application to HPV vaccination decisions among French adolescents., SSM Popul Health 2022 Mar; 17(): 101058.
-
2022Estimation of mid-and long-term benefits and hypothetical risk of Guillain-Barre syndrome after human papillomavirus vaccination among boys in France: A simulation study., Vaccine 2022 Jan; 40(2): 359-363.
-
2022What drives willingness to receive a new vaccine that prevents an emerging infectious disease? A discrete choice experiment among university students in Uganda., PLoS One 2022 ; 17(5): e0268063.
-
2021Quantifying healthcare and welfare sector workers’ preferences around COVID-19 vaccination: a cross-sectional, single-profile discrete-choice experiment in France., BMJ Open 2021 10; 11(10): e055148.
-
2021Optimising HPV vaccination communication to adolescents: A discrete choice experiment., Vaccine 2021 Jun; 39(29): 3916-3925.
-
2021Assessing the impact of preventive mass vaccination campaigns on yellow fever outbreaks in Africa: A population-level self-controlled case series study., PLoS Med 2021 Feb; 18(2): e1003523.
-
2021Quantifying preferences around vaccination against frequent, mild disease with risk for vulnerable persons: A discrete choice experiment among French hospital health care workers., Vaccine 2021 01; 39(5): 805-814.
-
2021Knowledge, beliefs and practices regarding prevention of bacterial meningitis in Burkina Faso, 5 years after MenAfriVac mass campaigns., PLoS One 2021 ; 16(7): e0253263.
-
2020Accounting for indirect protection in the benefit-risk ratio estimation of rotavirus vaccination in children under the age of 5 years, France, 2018., Euro Surveill 2020 08; 25(33): .
-
2019Meningococcal strain evolution, dusty dry air and respiratory tract infections: An explosive relationship., EBioMedicine 2019 04; 42(): 34-35.
-
2019Long-term effectiveness of MenAfriVac., Lancet Infect Dis 2019 03; 19(3): 228-229.
-
2015Response Strategies against Meningitis Epidemics after Elimination of Serogroup A Meningococci, Niger, Emerging Infect. Dis. 2015 Aug;21(8):1322-9.
-
2015Incidence, carriage and case-carrier ratios for meningococcal meningitis in the African meningitis belt: a systematic review and meta-analysis, PLoS ONE 2015;10(2):e0116725.
-
2015Streptococcus pneumoniae serotype 1 burden in the African meningitis belt: exploration of functionality in specific antibodies, Clin. Vaccine Immunol. 2015 Apr;22(4):404-12.
-
2014Drug sales data analysis for outbreak detection of infectious diseases: a systematic literature review, BMC Infect. Dis. 2014;14:604.
-
2014Surveillance of gastrointestinal disease in France using drug sales data, Epidemics 2014 Sep;8:1-8.
-
2014Spatio-temporal factors associated with meningococcal meningitis annual incidence at the health centre level in Niger, 2004-2010., PLoS Negl Trop Dis 2014 May; 8(5): e2899.
-
2013Knowledge of obstetric fistula prevention amongst young women in urban and rural Burkina Faso: a cross-sectional study, PLoS ONE 2013;8(12):e85921.
-
2013Antipneumococcal seroprevalence and pneumococcal carriage during a meningococcal epidemic in Burkina Faso, 2006, J. Infect. Dis. 2014 Apr;209(8):1241-50.
-
2013[Perception of vaccination and role of the pharmacist: A survey among final year pharmacy students in France], Ann Pharm Fr 2014 Mar;72(2):122-31.
-
2013Emergence of serogroup X meningococcal disease in Africa: need for a vaccine, Vaccine 2013 Jun;31(27):2852-61.
-
2013Seroprevalence of bactericidal, specific IgG antibodies and incidence of meningitis due to group A Neisseria meningitidis by age in Burkina Faso 2008, PLoS ONE 2013;8(2):e55486.
-
2012Pneumococcal serotype distribution among meningitis cases from Togo and Burkina Faso during 2007-2009, Vaccine 2012 Dec;30 Suppl 6:G41-5.
-
2012Pneumococci in the African meningitis belt: meningitis incidence and carriage prevalence in children and adults, PLoS ONE 2012;7(12):e52464.
-
2012Conjugate vaccine introduction in the African meningitis belt: meeting surveillance objectives, Trop. Med. Int. Health 2013 Jan;18(1):58-64.
-
2012A broad range assay for rapid detection and etiologic characterization of bacterial meningitis: performance testing in samples from sub-Sahara, Diagn. Microbiol. Infect. Dis. 2012 Sep;74(1):22-7.
-
2011Study of a localized meningococcal meningitis epidemic in Burkina Faso: incidence, carriage, and immunity, J. Infect. Dis. 2011 Dec;204(11):1787-95.
-
2011Emergence of epidemic Neisseria meningitidis serogroup X meningitis in Togo and Burkina Faso, PLoS ONE 2011;6(5):e19513.
-
2010Meningitis dipstick rapid test: evaluating diagnostic performance during an urban Neisseria meningitidis serogroup A outbreak, Burkina Faso, 2007, PLoS ONE 2010;5(6):e11086.
-
2010The Elimination of Haemophilus influenzae type b meningitis following conjugate vaccine introduction in Senegal, Pediatr. Infect. Dis. J. 2010 Jun;29(6):499-503.
-
2010African meningitis belt pneumococcal disease epidemiology indicates a need for an effective serotype 1 containing vaccine, including for older children and adults, BMC Infect. Dis. 2010;10:22.
-
2009A hypothetical explanatory model for meningococcal meningitis in the African meningitis belt, Int. J. Infect. Dis. 2010 Jul;14(7):e553-9.
-
2009Serotyping pneumococcal meningitis cases in the African meningitis belt by use of multiplex PCR with cerebrospinal fluid, J. Clin. Microbiol. 2010 Feb;48(2):612-4.
-
2009Incidence, seasonality, age distribution, and mortality of pneumococcal meningitis in Burkina Faso and Togo, Clin. Infect. Dis. 2009 Mar;48 Suppl 2:S181-9.
-
2009Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, Argentina, Appl. Environ. Microbiol. 2009 Mar;75(5):1395-401.
-
2008Association of respiratory tract infection symptoms and air humidity with meningococcal carriage in Burkina Faso, Trop. Med. Int. Health 2008 Dec;13(12):1543-52.
-
2007Haemophilus influenzae type b conjugate vaccine impact against purulent meningitis in Rwanda, Vaccine 2007 Sep;25(39-40):7001-5.
-
2007Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003, Emerging Infect. Dis. 2007 Jun;13(6):847-54.
-
2007Meningococcal carriage and immunity in western Burkina Faso, 2003, Vaccine 2007 Sep;25 Suppl 1:A42-6.
-
2007The epidemiology of Neisseria meningitidis meningitis in Togo during 2003-2005, Vaccine 2007 Sep;25 Suppl 1:A47-52.
-
2007Three cases of invasive meningococcal disease caused by a capsule null locus strain circulating among healthy carriers in Burkina Faso, J. Infect. Dis. 2007 Apr;195(7):1071-7.
-
2006The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005, Clin. Infect. Dis. 2006 Oct;43(7):817-22.
-
2006The impact of routine infant immunization with Haemophilus influenzae type b conjugate vaccine in Malawi, a country with high human immunodeficiency virus prevalence, Vaccine 2006 Sep;24(37-39):6232-9.
-
2006Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines, Expert Rev Vaccines 2006 Jun;5(3):319-36.
-
2006Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003, J. Infect. Dis. 2006 Mar;193(6):812-20.
-
2003Association of hormone replacement therapy with bronchial hyper-responsiveness, Respir Med 2003 Aug;97(8):990-2.
-
2003Maternal oral contraceptive use and atopic diseases in the offspring, Allergy 2003 Mar;58(3):229-32.
-
2002Prevalence and determinants of hormone replacement therapy in German women 1984-1995, Maturitas 2002 Oct;43(2):95-104.
-
2000Low levels of estradiol are associated with vertebral fractures in older men, but not women: the Rancho Bernardo Study, J. Clin. Endocrinol. Metab. 2000 Jan;85(1):219-23.
-
1990Effect of recombinant hirudin, a specific inhibitor of thrombin, on endotoxin-induced intravascular coagulation and acute lung injury in pigs, Am. Rev. Respir. Dis. 1990 Oct;142(4):782-8.